Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

8.85
Delayed Data
As of Feb 22
 +0.69 / +8.46%
Today’s Change
7.80
Today|||52-Week Range
18.00
-10.43%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$861.6M

Company Description

Lexicon Pharmaceuticals, Inc. operates as a biopharmaceutical company which focuses on the development of breakthrough treatments for human disease. It has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.

Contact Information

Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands Texas 77381-1160
P:(281) 863-3000
Investor Relations:

Employees

Shareholders

Other institutional77.36%
Individual stakeholders59.57%
Mutual fund holders27.60%

Top Executives

Lonnel CoatsPresident, Chief Executive Officer & Director
Jeffrey L. WadeCFO, EVP-Corporate & Administrative Affairs
Pablo LapuertaChief Medical Officer & EVP-Clinical Development
Alexander SantiniChief Commercial Officer & Executive VP
Brian T. CrumSecretary, Vice President & General Counsel